The PREDiCTm study, funded by Roche, provides Focus Panel molecular testing for the following tumour types:

  • Sarcoma (NOS)
  • Head and Neck squamous cell carcinoma (HNSCC)
  • Other indications (approval required)

Further information on the PREDiCTm study, including confirmation of eligibility for Focus Panel testing can be obtained by contacting Dr. Stephen Yip or Dr. Deepu Alex.

To order testing please use the PREDiCTm study-specific requisition, available here.